In the BioHarmony Drug Report Database
Hydrogen peroxide
Eskata (hydrogen peroxide) is a small molecule pharmaceutical. Hydrogen peroxide was first approved as Eskata on 2017-12-14. It is used to treat surgical wound infection in the USA. It is known to target transient receptor potential cation channel subfamily M member 2, transient receptor potential cation channel subfamily A member 1, and FAD-dependent glycine oxidase. Kundal pure refreshing whitening tooth (spearmint)’s patents are valid until 2035-07-04 (FDA).
Trade Name
|
Eskata |
|---|---|
Common Name
|
hydrogen peroxide |
ChEMBL ID
|
CHEMBL71595 |
Indication
|
surgical wound infection |
Drug Class
|
Image (chem structure or protein)